Table 1.

Adverse Reactions and Dropouts After Administration of Omidenepag Isopropyl

Adverse Reactions (4 Patients, 7.4%)	Number of Patients	Time Point	Progress
Conjunctival hyperemia	3 (5.6%)	1 week	Discontinued administration
		2 weeks	Discontinued administration
		1 month	Continued administration
Eye pain	1 (1.9%)	1 month	Discontinued administration
Dropouts (5 Patients, 9.3%)	Number of Patients	Time Point	Details
Adverse reactions	3 (5.6%)	1 week	Conjunctival hyperemia
		2 weeks	Conjunctival hyperemia
		1 month	Eye pain
Insufficient IOP lowering effect	1 (1.9%)	2 months
Discontinuation of follow-up at our clinic	1 (1.9%)	1 month

Abbreviation: IOP, intraocular pressure.